Credit Suisse Group Trims Fulgent Genetics (NASDAQ:FLGT) Target Price to $45.00
Fulgent Genetics (NASDAQ:FLGT – Get Rating) had its price objective trimmed by Credit Suisse Group from $50.00 to $45.00 in a research report report published on Thursday morning, The Fly reports. The firm currently has an outperform rating on the stock. Several other research analysts also recently weighed in on FLGT. Piper Sandler downgraded shares of Fulgent Genetics from an overweight rating…
View On WordPress










